All things considered, I just named seven companies who can not only afford Acadia Pharmaceuticals, but also legitimately need what Nuplazid can offer. The big question is whether big pharma values ACAD stock the same way that Acadia …
Acadia Pharmaceuticals (ACAD) briefly rallied, then dipped nearly 1% early …
Therefore, let’s take a closer look at what smart money thinks about ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). At Q3’s end, a total of 24 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -8% from …
Some better-ranked stocks in the health care sector are ACADIA Pharmaceuticals Inc. ACAD, Celgene Corporation CELG and Aduro ... 2017 and 2018 have inched …
ACADIA Pharmaceuticals Inc. (ACAD) announced after the bell Wednesday that the FDA ... the middle portion of Wednesday's session and closed up by 0.28 at $39.14. The stock is now up 2.31 on 562K shares after the bell.
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here. ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD announced the …
Glenn Baity, EVP of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reportedly Sold 38,097 shares of the company’s …
Yet another gain for stocks on Thursday sent the Standard & Poor's 500 index higher for an eighth straight day, its longest winning streak since July 2013. It's the latest step higher for a market that's methodically climbed to record after record …
Proc Natl Acad Sci USA 2007;104:20932–20937 ... Register now to create your own custom streaming stock watchlist. …
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) announced the initiation of a phase ... associated with Parkinson’s disease psychosis in the United States. ACADIA’s stock was up 7.2% in aftermarket hours on Wednesday following …